Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02040792 · ClinicalTrials.gov registry record · Phase 2
A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2 study, sponsored by Mylan.
- Completed
- Registry status
- Phase 2
- Development phase
- 355
- Enrollment target
NCT02040792: Completed Phase 2 study, sponsored by Mylan.
NCT02040792 is a Phase 2 study that has completed, run by Mylan. The registered enrollment target is 355 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (167% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02040792, a Phase 2 study, has completed, sponsored by Mylan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 355 participants
- Enrollment target
Study Summary
This study evaluated the safety and efficacy of four doses of TD-4208 and a placebo product when administered once daily for 28 days using a jet nebulizer to patients with moderate to severe chronic obstructive pulmonary disease.
Interventions
- DRUG Placebo
- DRUG TD-4208
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 355 participants |
| Start Date | 2014-05 |
| Est. Completion | 2014-08 |
| Phase | Phase 2 |
What the finished NCT02040792 record still lists
NCT02040792 is an interventional study that assigns participants to a tested intervention. The registered 355 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (167% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02040792 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02040792 about?
NCT02040792 is a clinical study titled "A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)". This study evaluated the safety and efficacy of four doses of TD-4208 and a placebo product when administered once daily for 28 days using a jet nebulizer to patients with moderate to severe chronic obstructive pulmonary disease.
What is the current status of trial NCT02040792?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 355 participants. The study started on 2014-05. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02040792?
The interventions under investigation include: Placebo (DRUG), TD-4208 (DRUG).
Who is sponsoring clinical trial NCT02040792?
This trial is sponsored by Mylan, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02040792's enrollment target sits among peer trials
355 128th of 2000 higher than 1,873 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07133308 · 355 participants · Phase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- NCT07193511 · 355 participants · Phase 1
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
- NCT06077838 · 356 participants · NA
RELAXaHEAD for Headache Patients (Phase III)
- NCT06293469 · 356 participants · NA
Accelerated Flap Coverage in Severe Lower Extremity Trauma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia